A phase 2a multicenter, double-blind, placebo-controlled, crossover trial to investigate the efficacy, safety, and toleration of CP-866,087 (a high-affinity mu-opioid receptor antagonist) in premenopausal women diagnosed with female sexual arousal disorder (FSAD)

Miguel Orri, Lucy Abraham, Annamaria Giraldi

9 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'A phase 2a multicenter, double-blind, placebo-controlled, crossover trial to investigate the efficacy, safety, and toleration of CP-866,087 (a high-affinity mu-opioid receptor antagonist) in premenopausal women diagnosed with female sexual arousal disorder (FSAD)'. Sammen danner de et unikt fingeraftryk.

Medicin og biovidenskab